Transdermal administration of drugs that penetrate, in this case directly into the blood circulation, has many advantages and is promising for many drugs thanks to its easy application and good patient compliance. (S)-8-Methyl-6,9-diazaspiro[4.5]decan-7,10-dione (alaptide), has been studied as a potential chemical permeation enhancer. Based on its structure, four selected piperazine-2,5-diones were synthesized by means of multi-step synthetic pathways. All the compounds were investigated on their ability to enhance the permeation of the model drug theophylline from the hydrophilic medium propylene glycol:water (1:1). In vitro experiments were performed using vertical Franz diffusion cells at constant temperature 34 ± 0.5 °C and using full-thickness pig (Sus scrofa f. domestica) ear skin. Withdrawn samples were analyzed by RP-HPLC for determination of the permeated amount of theophylline. All the compounds were applied in ratio 1:10 (w/w) relative to the amount of theophylline. One hour after application, the permeated amount of theophylline from formulations with alaptide and (3S,6S)-3,6-dimethylpiperazine-2,5-dione, was ca. 15- and 12-fold higher, respectively, than from the formulation without the tested compounds. Despite the enhancement ratio of both enhancers in a steady state was ca. 2.3, the pseudo-enhancement ratio in the time range from 1 to 3 h was 4.4. These enhancement ratios indicate that the compounds are able to enhance the permeation of agents through the skin; however, the short-term application of both compound formulations seems to be more advantageous. In addition, the screening of the cytotoxicity of all the prepared compounds was performed using three cell lines, and the compounds did not show any significant toxic effect.

Department of Chemical Biology and Genetics Centre of the Region Hana for Biotechnological and Agricultural Research Faculty of Science Palacky University Slechtitelu 27 783 71 Olomouc Czech Republic

Department of Chemical Drugs Faculty of Pharmacy University of Veterinary and Pharmaceutical Sciences Brno Palackeho 1946 1 612 42 Brno Czech Republic

Department of Neurology University Hospital in Olomouc 1 P Pavlova 6 775 20 Olomouc Czech Republic

Global Change Research Institute CAS Belidla 986 4a 603 00 Brno Czech Republic

Institute of Analytical Chemistry of the CAS Veveri 97 602 00 Brno Czech Republic

Regional Centre of Advanced Technologies and Materials Palacky University Slechtitelu 27 783 71 Olomouc Czech Republic

Zobrazit více v PubMed

Shargel L., Yu A.B.C. Applied Biopharmaceutics and Pharmacokinetics. 7th ed. McGraw-Hill; New York, NY, USA: 2016.

Watkinson A.C., Kearney M.C., Quinn H.L., Courtenay A.J., Donnelly R.F. Future of the transdermal drug delivery market—Have we barely touched the surface? Expert Opin. Drug Deliv. 2016;13:523–532. doi: 10.1517/17425247.2016.1130034. PubMed DOI

Alkilani A.Z., McCrudden M.T.C., Donnelly R.F. Transdermal drug delivery: Innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics. 2015;7:438–470. doi: 10.3390/pharmaceutics7040438. PubMed DOI PMC

Forslind B., Lindberg M. Skin, Hair, Nails: Structure and Function. Marcel & Dekker; New York, NY, USA: 2004.

Cernikova A., Jampilek J. Structure modification of drugs influencing their bioavailability and therapeutic effect. Chem. Listy. 2014;108:7–16.

Jampilek J. Transdermal application of drugs and techniques affecting skin barrier. J. Bioequiv. Availab. 2013;5:233–235. doi: 10.4172/jbb.1000164. DOI

Jampilek J., Brychtova K. Azone analogues: Classification, design, and transdermal penetration principles. Med. Res. Rev. 2012;32:907–947. doi: 10.1002/med.20227. PubMed DOI

Patil U.K., Saraogi R. Natural products as potential drug permeation enhancer in transdermal drug delivery system. Arch. Dermatol. Res. 2014;306:419–426. doi: 10.1007/s00403-014-1445-y. PubMed DOI

Thong H.Y., Zhai H., Maibach H.I. Percutaneous penetration enhancers: An overview. Skin Pharmacol. Physiol. 2007;20:272–282. doi: 10.1159/000107575. PubMed DOI

Jampilek J. Azone and its analogues. In: Dragicevic-Curic N., Maibach H.I., editors. Percutaneous Penetration Enhancers—Chemical Methods in Penetration Enhancement: Modification of the Stratum Corneum. Springer; Berlin/Heidelberg, Germany: 2015. pp. 69–106.

Kasafirek E., Vanzura J., Krejci I., Krepelka J., Dlabac A., Valchar M. 2,5-Piperazinedione Derivs. Belgian Patent 897843, 20 May 1984; CS 231227. Czechoslovakian Patent. 1986 Jan 26;

Radl S., Kasafirek E., Krejci I. Alaptide. Drug. Future. 1990;15:445–447. doi: 10.1358/dof.1990.015.05.127620. DOI

Jampilek J., Opatrilova R., Coufalova L., Cernikova A., Dohnal J. Utilization of Alaptide as Transdermal Penetration Modifier in Pharmaceutical Compositions for Human and Veterinary Applications Containing Anti-Inflammatory Drugs and/or Antimicrobial Chemotherapeutics. WO/2013/020527 A1, Feb 14, 2013.

Jampilek J., Opatrilova R., Dvorakova L., Brychtova K., Dohnal J. Utilization of Alaptide as Transdermal Penetration Modifier in Pharmaceutical Compositions for Human and Veterinary Applications Containing Non-Steroidal Anti-Inflammatory and/or Antipyretic-Analgesic Drugs. CZ 304915 B6. Czech Patent. 2014 Dec 10;

Jampilek J., Opatrilova R., Dvorakova L., Cernikova A., Dohnal J. Utilization of Alaptide as Transdermal Penetration Modifier in Pharmaceutical Compositions for Human and Veterinary Applications Containing Antimicrobial Chemotherapeutics. CZ 306686 B6. Czech Patent. 2017 Mar 29;

Jampilek J., Opatrilova R., Dvorakova L., Dohnal J. Utilization of Alaptide as Transdermal Penetration Modifier in Pharmaceutical Compositions for human and Veterinary Applications Containing Glucocorticoids. CZ 306770 B6. Czech Patent. 2017 May 17;

Jampilek J., Dohnal J. Alaptide as transdermal permeation modifier. In: Dragicevic-Curic N., Maibach H.I., editors. Percutaneous Penetration Enhancers—Chemical Methods in Penetration Enhancement: Modification of the Stratum Corneum. Springer; Berlin/Heidelberg, Germany: 2015. pp. 115–132.

Cernikova A., Bobal P., Bobalova J., Dohnal J., Jampilek J. Investigation of permeation of acyclovir through skin using alaptide. Acta Chromatogr. 2018;30:62–65. doi: 10.1556/1326.2017.00242. DOI

Jampilek J., Opatrilova R., Rezacova A., Oktabec Z., Dohnal J. Alaptide: Methods of Effecting Its Solubility, Membrane Permeation and Pharmaceutical Compositions for Human and/or Veterinary Applications. WO/2014/019556 A1, Feb 6, 2014.

Kasafirek E., Rybak M., Krejci I., Sturs A., Krepela E., Sedo A. Two-step generation of spirocyclic dipeptides from linear peptide ethyl ester precursors. Life Sci. 1992;50:187–193. doi: 10.1016/0024-3205(92)90271-P. PubMed DOI

Vallejos S., Estevez P., Ibeas S., Munoz A., Garcia F.C., Serna F., Garcia J.M. Selective and highly sensitive fluorescent probe of Hg2+ in organic and aqueous media: The role of a polymer network in extending the sensing phenomena to water environments. Sens. Actuators B Chem. 2011;157:686–690. doi: 10.1016/j.snb.2011.05.041. DOI

Chen F.M.F., Stainauer R., Benoiton N.L. Mixed anhydrides in peptide synthesis. Reduction of urethane formation and racemization using N-methylpiperidine as the tertiary amine base. J. Org. Chem. 1983;48:2939–2941. doi: 10.1021/jo00165a036. DOI

Pizova H., Bobal P. Optimized and scalable synthesis of propylphosphonic anhydride for general use. Tetrahedron Lett. 2015;56:2014–2017. doi: 10.1016/j.tetlet.2015.02.126. DOI

Pizova H., Havelkova M., Stepankova S., Bak A., Kauerova T., Kozik V., Oravec M., Imramovsky A., Kollar P., Bobal P., et al. Proline-based carbamates as cholinesterase inhibitors. Molecules. 2017;22:1969. doi: 10.3390/molecules22111969. PubMed DOI PMC

Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 2001;46:3–26. doi: 10.1016/S0169-409X(00)00129-0. PubMed DOI

Bak A., Kozik V., Smolinski A., Jampilek J. Multidimensional (3D/4D-QSAR) probability-guided pharmacophore mapping: Investigation of activity profile for a series of drug absorption promoters. RSC Adv. 2016;6:76183–76205. doi: 10.1039/C6RA15820J. DOI

Bak A., Kozik V., Smolinski S., Jampilek J. In silico estimation of basic activity-relevant parameters for a set of drug absorption promoters. SAR QSAR Environ. Res. 2017;28:427–449. doi: 10.1080/1062936X.2017.1327459. PubMed DOI

Kapustikova I., Bak A., Gonec T., Kos J., Kozik V., Jampilek J. Investigation of hydro-lipophilic properties of N-alkoxyphenylhydroxynaphthalenecarboxamides. Molecules. 2018;23:1635. doi: 10.3390/molecules23071635. PubMed DOI PMC

Bąk A., Kozik V., Walczak M., Fraczyk J., Kaminski Z., Kolesinska B., Smolinski A., Jampilek J. Towards intelligent drug design system: Application of artificial dipeptide receptor library in QSAR-oriented study. Molecules. 2018;23:1964. doi: 10.3390/molecules23081964. PubMed DOI PMC

Malik I., Csollei J., Solovic I., Pospisilova S., Michnova H., Jampilek J., Cizek A., Kapustikova I., Curillova J., Pechacova M., et al. Dibasic derivatives of phenylcarbamic acid against mycobacterial strains: Old drugs and new tricks? Molecules. 2018;23:2493. doi: 10.3390/molecules23102493. PubMed DOI PMC

Bak A., Kozik V., Malik I., Jampilek J., Smolinski S. Probability-driven 3D pharmacophore mapping of antimycobacterial potential of hybrid molecules combining phenylcarbamoyloxy and N-arylpiperazine fragments. SAR QSAR Environ. Res. 2018;29:801–821. doi: 10.1080/1062936X.2018.1517278. PubMed DOI

Japertas P., Didziapetris R., Petrauskas A. Fragmental methods in the analysis of biological activities of diverse compound sets. Mini-Rev. Med. Chem. 2003;3:797–808. doi: 10.2174/1389557033487601. PubMed DOI

DeWitte R.S. Understanding polyelectrolytes. Mod. Drug Discov. 2004;7:41–44.

Franz T.J. Percutaneous absorption. On the relevance of In vitro data. J. Investig. Dermatol. 1975;64:190–195. doi: 10.1111/1523-1747.ep12533356. PubMed DOI

Williams A.C., Barry B.W. Urea analogues in propylene glycol as penetration enhancers in human skin. Int. J. Pharm. 1989;56:43–50. doi: 10.1016/0378-5173(89)90059-8. DOI

Yamane M.A., Williams A.C., Barry B.W. Terpene penetration enhancers in propylene glycol/water co-solvent systems: Effectiveness and mechanism of action. J. Pharm. Pharmacol. 1995;47:978–989. doi: 10.1111/j.2042-7158.1995.tb03282.x. PubMed DOI

Ni N., El-Sayed M.M., Sanghvi T., Yalkowsky S.H. Estimation of the effect of NaCl on the solubility of organic compounds in aqueous solutions. J. Pharm. Sci. 2000;89:1620–1625. doi: 10.1002/1520-6017(200012)89:12<1620::AID-JPS13>3.3.CO;2-E. PubMed DOI

Katz M., Ben-Shlush I., Kolusheva S., Jelinek R. Rapid colorimetric screening of drug interaction and penetration through lipid barriers. Pharm. Res. 2006;23:580–588. doi: 10.1007/s11095-006-9569-1. PubMed DOI

Fang J.Y., Tsai T.H., Hung C.F., Wong W.W. Development and evaluation of the essential oil from Magnolia fargesii for enhancing the transdermal absorption of theophylline and cianidanol. J. Pharm. Pharmacol. 2004;56:1493–1500. doi: 10.1211/0022357044823. PubMed DOI

Sloan K.B., Beall H.D., Taylor H.E., Getz J.J., Villaneuva R., Nipper R., Smith K. Transdermal delivery of theophylline from alcohol vehicles. Int. J. Pharm. 1998;171:185–193. doi: 10.1016/S0378-5173(98)00190-2. DOI

Abd E., Yousef S.A., Pastore M.N., Telaprolu K., Mohammed Y.H., Namjoshi S., Grice J.E., Roberts M.S. Skin models for the testing of transdermal drugs. Clin. Pharmacol. 2016;8:163–176. doi: 10.2147/CPAA.S64788. PubMed DOI PMC

Jacobi U., Kaiser M., Toll R., Mangelsdorf S., Audring H., Otberg N., Sterry W., Lademann J. Porcine ear skin: An In vitro model for human skin. Skin Res. Technol. 2007;13:19–24. doi: 10.1111/j.1600-0846.2006.00179.x. PubMed DOI

Herkenne C., Naik A., Kalia Y.N., Hadgraft J., Guy R.H. Pig ear skin ex vivo as a model for in vivo dermatopharmacokinetic studies in man. Pharm. Res. 2006;23:1850–1856. doi: 10.1007/s11095-006-9011-8. PubMed DOI

Todo H. Transdermal permeation of drugs in various animal species. Pharmaceutics. 2017;9:33. doi: 10.3390/pharmaceutics9030033. PubMed DOI PMC

Meyer W., Schwarz K., Neurand K.T. The skin of domestic mammals as a model for the human skin, with special reference to the domestic pig. Curr. Probl. Dermatol. 1978;7:39–52. PubMed

Suffness M., Douros J. Current status of the NCI plant and animal product program. J. Nat. Prod. 1982;45:1–14. doi: 10.1021/np50019a001. PubMed DOI

Beagle L.K., Hansen F.K., Monbaliu J.C.M., DesRosiers M.P., Phillips A.M., Stevens C.V., Katritzky A.R. Efficient Synthesis of 2,5-diketopiperazines by Staudinger-mediated cyclization. Synlett. 2012;23:2337–2340.

Ishibashi N., Kouge K., Shinoda I., Kanehisa H., Okai H. Studies on flavored peptides. Part V. A mechanism for bitter taste sensibility in peptides. Agric. Biol. Chem. 1988;52:819–827.

Chu D.T.W., Nordeen C.W., Hardy D.J., Swanson R.N., Giardina W.J., Pernet A.G., Plattner J.J. Synthesis, antibacterial activities, and pharmacological properties of enantiomers of temafloxacin hydrochloride. J. Med. Chem. 1991;34:168–174. doi: 10.1021/jm00105a025. PubMed DOI

Campbell T.D., Hart C.A., Febrian R., Cheneler M.L., Bracher P.J. The opposite effect of K+ and Na+ on the hydrolysis of linear and cyclic dipeptides. Tetrahedron Lett. 2018;59:2264–2267. doi: 10.1016/j.tetlet.2018.04.073. DOI

Woodard R.W. Stereochemistry of cyclic dipeptides. Assignment of the prochiral methylenes of 1-aminocyclopropane-1-carboxylic acid. J. Org. Chem. 1985;50:4796–4799. doi: 10.1021/jo00224a028. DOI

OECD Guidelines for the Testing of Chemicals, Section 4, Test No. 428: Skin Absorption: In Vitro Method. OECD Publishing; Paris, France: 2004.

WHO . Environmental Health Criteria (EHC 235)—Dermal Absorption. WHO Press; Geneva, Switzerland: 2006.

Shah J.C. Application of kinetic model to In vitro percutaneous permeation of drugs. Int. J. Pharm. 1996;133:179–189. doi: 10.1016/0378-5173(96)04440-7. DOI

Steffansen B., Brodin B., Uhd Nielsen C. Molecular Biopharmaceutics: Aspects of Drug Characterisation, Drug Delivery and Dosage Form Evaluation. Pharmaceutical Press; London, UK: 2010.

Heterocycles in Medicinal Chemistry